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Substrate preference and phosphatidylinositol monophosphate
inhibition of the catalytic domain of the PAS kinase PASKIN
Abstract
The PAS domain serine/threonine kinase PASKIN, or PAS kinase, links energy flux and protein
synthesis in yeast, regulates glycogen synthesis and protein translation in mammals, and might be
involved in insulin regulation in the pancreas. According to the current model, binding of a putative
ligand to the PAS domain disinhibits the kinase domain, leading to PASKIN autophosphorylation and
increased kinase activity. Up to date, only synthetic but no endogenous PASKIN ligands have been
reported. Here, we identified a number of novel PASKIN kinase targets, including ribosomal protein S6.
Together with our previous identification of eukaryotic translation elongation factor eEF1A1, this
suggests a role for PASKIN in the regulation of mammalian protein translation. While searching for
endogenous PASKIN ligands, we found that various phospholipids can bind PASKIN and stimulate its
autophosphorylation. Interestingly, strongest binding and autophosphorylation was achieved with
monophosphorylated phosphatidylinositols. However, stimulated PASKIN autophosphorylation did not
correlate with ribosomal protein S6 and eEF1A1 target phosphorylation. Whereas autophosphorylation
was enhanced by monophosphorylated phosphatidylinositols, di- and triphosphorylated
phosphatidylinositols inhibited autophosphorylation. In contrast, target phosphorylation was always
inhibited, with highest efficiency of di- and tri-phosphorylated phosphatidylinositols. Since
phosphatidylinositol monophosphates were found to interact with the kinase rather than with the PAS
domain, these data suggest a multi-ligand regulation of PASKIN activity, including a still unknown PAS
domain binding/activating ligand and kinase domain binding modulatory phosphatidylinositol
phosphates.
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SUMMARY 
 
The PAS domain serine/threonine kinase PASKIN, or PAS kinase, links energy flux and protein 
synthesis in yeast, regulates glycogen synthesis and protein translation in mammals, and might be 
involved in insulin regulation in the pancreas. According to the current model, binding of a putative 
ligand to the PAS domain disinhibits the kinase domain, leading to PASKIN autophosphorylation and 
increased kinase activity. Up to date, only synthetic but no endogenous PASKIN ligands have been 
reported. Here, we identified a number of novel PASKIN kinase targets, including ribosomal protein 
S6. Together with our previous identification of eukaryotic translation elongation factor eEF1A1, this 
suggests a role for PASKIN in the regulation of mammalian protein translation. While searching for 
endogenous PASKIN ligands, we found that various phospholipids can bind PASKIN and stimulate its 
autophosphorylation. Interestingly, strongest binding and autophosphorylation was achieved with 
monophosphorylated phosphatidylinositols. However, stimulated PASKIN autophosphorylation did 
not correlate with ribosomal protein S6 and eEF1A1 target phosphorylation. Whereas 
autophosphorylation was enhanced by monophosphorylated phosphatidylinositols, di- and tri-
phosphorylated phosphatidylinositols inhibited autophosphorylation. In contrast, target 
phosphorylation was always inhibited, with highest efficiency of di- and tri-phosphorylated 
phosphatidylinositols. Since phosphatidylinositol monophosphates were found to interact with the 
kinase rather than with the PAS domain, these data suggest a multi-ligand regulation of PASKIN 
activity, including a still unknown PAS domain binding/activating ligand and kinase domain binding 
modulatory phosphatidylinositol phosphates. 
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INTRODUCTION 
 
In lower organisms, the PAS (Per-Arnt-Sim)
6
 domain is often found in environmental protein sensors 
involved in the perception of light intensity, oxygen partial pressure, redox potentials, voltage and 
certain ligands [1]. In mammals, the PAS domain is mainly found as a heterodimerization interface of 
transcription factors involved in dioxin signalling, the circadian clock and oxygen sensing [2-4]. We 
and others previously identified a novel mammalian PAS protein, alternatively called PASKIN [5] or 
PAS kinase [6]. PASKIN contains two PAS domains (PAS A and PAS B) and a serine/threonine 
kinase domain which might be regulated in cis by binding of so far unknown ligands to the PAS 
domain [7]. PASKIN shows a striking structural similarity to the bacterial oxygen sensor FixL that 
contains an oxygen-binding heme group within its PAS domain [5]. Following derepression by ligand 
binding, autophosphorylation in trans results in the "switch-on" of the kinase domain of FixL. A 
similar mode of activation has been suggested for PASKIN, too [6]. 
 PSK1 and PSK2, the budding yeast homologs of PASKIN, phosphorylate three translation 
factors and two enzymes involved in the regulation of glycogen and trehalose synthesis, thereby 
coordinately controlling translation and sugar flux [8]. Further experiments revealed that under stress 
conditions, yeast PSK regulates Ugp1 translocation to the plasma membrane where it increases cell 
wall glucan synthesis at the expense of glycogen storage. In the absence of PSKs, glycogen rather than 
glucan is produced, affecting the strength of the cell wall [9]. Two independent cell stressors have 
been identified to activate PSKs in yeast. Cell integrity stress (e.g. heat shock or SDS treatment) 
required the Wsc1 membrane stress sensor, and growth in non-glucose carbon sources (e.g. raffinose) 
required the AMP-dependent kinase (AMPK) homolog Snf1. While PSK2 was predominantly 
activated by Wsc1, PSK1 was indispensable for Snf1 function [10].  
 In mammals, PASKIN-dependent phosphorylation inhibits the activity of glycogen synthase 
(GYS) [11]. PASKIN has also been suggested to be required for glucose-dependent transcriptional 
induction of preproinsulin gene expression, which might be related to PASKIN-dependent regulation 
of the nuclear import of pancreatic duodenal homeobox-1 (PDX1) transcription factor [12,13]. 
However, by generating PASKIN-deficient knock-out mice, we could not demonstrate any PASKIN-
dependent difference in insulin gene expression or glucose tolerance [14,15]. Moreover, conflicting 
data were also reported on the resistance of these Paskin knock-out mice towards high fat diet-induced 
metabolic syndrome [16,17].  
 We previously found that the eukaryotic translational elongation factor (eEF)1A1 is 
phosphorylated by PASKIN at T432 [18]. However, the role of this modification in translational 
control awaits further studies. By screening for new PASKIN kinase targets, we demonstrate here that 
another crucial translation factor, ribosomal protein S6, can be phosphorylated by PASKIN, 
suggesting that PASKIN regulates protein translation not only in yeast but also in mammals. 
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Moreover, we identified phospholipid ligands binding to PASKIN and studied their effects on 
PASKIN activity. 
 
RESULTS 
 
Identification of novel PASKIN kinase targets 
 
Two approaches were applied to search for novel mammalian PASKIN targets: yeast two-hybrid and 
phosphorylation of peptide arrays. By yeast two-hybrid screening of a HeLa cell-derived library, we 
previously identified eEF1A1 as a PASKIN target [18]. In addition to novel proteins interacting with 
PASKIN, we also screened for novel proteins which can be phosphorylated by PASKIN. Therefore, a 
peptide microarray containing 1176 potential phosphoacceptor peptides was incubated with 
recombinant PASKIN and radioactively labelled ATP. As shown in Fig. 1A, distinct peptides were 
strongly phosphorylated by PASKIN (see supplemental Table S1 for a list of the 75 most strongly 
phosphorylated peptides). The consensus phosphoacceptor site of the 30 most strongly phosphorylated 
peptides was found to be similar to protein kinase (PK) A and C motifs (Fig. 1B). These data are 
supported by recent findings based on a combinatorial peptide library, demonstrating a strong 
preference for arginine at position -3 [19]. Accordingly, from the 75 strongest hits in our screening, 70 
hits indeed contain arginine three amino acids before the serine or threonine phosphoacceptor site 
(supplemental table S1). Several proteins were identified more than once either because more than one 
phosphoacceptor site within the same protein could be phosphorylated, or because overlapping 
peptides containing the same phosphoacceptor site were present, or because the peptide was derived 
from the same site but from distinct species. Seventeen different pyruvate kinase-derived peptides, for 
example, were identified by this way. One of the proteins listed in Fig. 1B is glycogen synthase which 
has previously been identified by others as a PASKIN kinase target [11]. Thus, glycogen synthase 
identification confirmed the feasibility of our approach and was used as a reference target protein for 
the next experiments.  
 To corroborate PASKIN-dependent phosphorylation of these rather short arrayed peptides, 11 
of the most strongly phosphorylated candidate PASKIN kinase targets were synthesized as 20-mer 
peptides and used for in vitro phosphorylation by recombinant PASKIN (see supplemental Table S2 
for sequences and references). As shown in Fig. 1C, 6 peptides were significantly better 
phosphorylated by PASKIN than the unrelated control peptide and 3 of them showed an even stronger 
phosphorylation than the known PASKIN targets GYS and PDX1, i.e. 40S ribosomal protein S6 (S6), 
phosphorylase kinase β (PHKB) and phosphofructo kinase/fructose bisphosphatase (PFKFB). 
 
Ribosomal protein S6 is phosphorylated by PASKIN 
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Because others and we previously reported a role for PASKIN in protein translation [8,18], the finding 
that a S6-derived peptide was strongly phosphorylated by PASKIN was further investigated. S6 is a 
target of the mTOR signalling pathway that regulates nutrient-dependent protein translation by p70 S6 
kinase (p70S6K)-mediated phosphorylation of S6 serine residues 235 and 236 [20]. Therefore, 
recombinant S6 was expressed and purified either as wild-type, C-terminally truncated or 
Ser235/236Ala double-mutant GST fusion protein (Fig. 2A). As shown in Fig. 2B, PASKIN 
phosphorylated wild-type but not truncated or serine double-mutant S6 in vitro, suggesting that 
PASKIN also targets S6 at serines 235/236. 
 To analyse PASKIN-dependent phosphorylation of endogenous S6 in vivo, we used MEFs 
derived from either Paskin
+/+
 wild-type or Paskin
-/-
 knock-out mice [14]. However, as shown in Fig. 
2C, no difference in constitutive p70S6K or S6 phosphorylation could be detected in these cells. Since 
basal S6 phosphorylation by p70S6K might overcome subtle changes caused by PASKIN, we next 
used MEFs deficient for both genes encoding mouse p70S6K (S6K1
-/-
/S6K2
-/-
) [21], and transiently 
overexpressed full-length PASKIN or an N-terminally truncated version preserving the kinase domain 
in these cells. Whereas S6 total protein levels remained unchanged, phosphorylated S6 was strongly 
reduced in S6K1
-/-
/S6K2
-/-
 double knock-out MEFs (Fig. 2D). Interestingly, overexpression of myc-
tagged PASKIN, or its kinase domain alone, led to increased phosphorylation of S6 at serines 235/236 
(Fig. 2D). In summary, while these data demonstrate that S6 is a new in vitro target, PASKIN can also 
phosphorylate S6 in vivo and might even partially contribute to the residual S6 phosphorylation 
observed in p70S6K-deficient cells [22]. However, a more prominent S6 kinase function in vivo 
probably awaits the identification of the endogenous stimulus of PASKIN catalytic activity. 
 
Autophosphorylation of recombinant PASKIN is activated by phospholipids 
 
A possible mechanism of PASKIN activation in vivo might be the binding of a so far unknown ligand 
like it has been suggested previously [7]. However, no endogenous PASKIN ligand is known so far. 
By comparing the activity of PASKIN with PKCδ we obtained first hints for a potential endogenous 
ligand. We previously reported that both PASKIN and PKCδ phosphorylate the eukaryotic translation 
elongation factor eEF1A1 [18], and both kinases are known to autophosphorylate themselves [6,23]. 
Because PKCδ kinase activity is known to be stimulated by diacylglycerol (DAG) and 
phosphatidylserine (PS) [24], we wondered whether other similarities exist between PASKIN and 
PKCδ. Interestingly, a mixture of PS and DAG (used in the form of dioctanoylglycerol, DOG) not 
only enhanced PKCδ but also PASKIN autophosphorylation (Fig. 3A).  
 In order to systematically analyze the lipid activation of PASKIN, all major phospholipids were 
compared for their effects on PASKIN and PKCδ autophosphorylation. As shown in Fig. 3B, all tested 
phospholipids but not DOG alone increased PASKIN autophosphorylation. In contrast, PKCδ 
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autophosphorylation was induced by DOG alone, to some extent also by PS or PC, but all other 
phospholipids had only marginal effects on PKCδ. As shown before [24], a mixture between DOG and 
PS was required to maximally induce PKCδ activity. However, combining DOG with phospholipids 
did not further induce PASKIN (data not shown).  
 The rather unselective stimulation of PASKIN activity by all tested phospholipids suggested 
that the core phospholipid moiety might confer PASKIN binding. Indeed, as shown in Fig. 3C 
phosphatidic acid alone was sufficient to stimulate PASKIN autophosphorylation. The finding that PA 
but not DOG strongly bound PASKIN suggested that PLD might target PASKIN by converting 
phospholipids into PA. To directly demonstrate this assumption, 96-well plates were coated with 
constant amounts (1 µg) of PC. Following treatment with phospholipase (PL) D or C, increasing 
amounts of PASKIN were added and detected by ELISA. As shown in Fig. 3D, PASKIN bound with 
clearly higher affinity to PA than to PC. However, lipid binding was restored when PC was treated 
with PLD (generating PA) but not with PLC (generating DAG). 
 
Inositol phosphorylation determines the affinity of phospatidylinositol interaction with 
PASKIN 
 
The experiments described above suggested that an isolated phosphate group such as in PA is 
necessary for maximal PASKIN-lipid interaction. Because phosphatidylinositols (PtdIns) with varying 
numbers of phosphate groups belong to the most important cellular lipid signalling molecules, we next 
investigated whether the number and location of the phosphate groups on the inositol ring affect their 
interaction with PASKIN. Therefore, dot blots containing mono-, di- and tri-phosphorylated PtdIns 
were incubated with recombinant PASKIN and immunodetected using anti-PASKIN antibodies. 
Surprisingly, whereas unphosphorylated PI showed only relatively low PASKIN binding, this 
interaction was strongly increased by the presence of a single phosphate group in PtdIns(4)P, and 
reduced again when two or three phosphate groups were present in PtdIns(4,5)P2 and PtdIns(3,4,5)P3, 
respectively (Fig. 4A). This finding was corroborated by using dot blots with increasing amounts of all 
possible PtdIns-phosphates: PASKIN dose-dependently bound better PtdIns-monophosphates than 
PtdIns-diphosphates, and non-phosphorylated or tri-phosphorylated PtdIns bound PASKIN only 
weakly (Fig. 4B, left panel). Similar results were obtained with autophosphorylated PASKIN (Fig. 4B, 
right panel), suggesting that PASKIN phosphorylation status does not interfere with selective PtdIns-
monophosphate binding. 
 To localise the region responsible for PtdIns-monophosphate binding, four different fragments 
of PASKIN as indicated in Fig. 4C (left panel) were expressed and purified as His6-tagged fusion 
proteins. However, only the kinase (KIN) domain of PASKIN bound PtdIns-monophosphates (Fig. 
4C, right panel), rather than the previously suggested ligand-binding PAS domain (data not shown). 
We next sought to determine the effects of differently phosphorylated PtdIns on PASKIN 
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autophosphorylation. As shown in Fig. 4D, autophosphorylation was dose-dependently enhanced by 
all three PtdIns-monophosphates, whereas especially high concentrations of PtdIns(4,5)P2 and 
PtdIns(3,4,5)P3 even inhibited autophosphorylation, establishing a structure-function relationship 
between kinase domain-lipid interaction and kinase activity. 
 
PtdIns-monophosphate-dependent regulation of PASKIN target phosphorylation 
 
Because PtdIns-monophosphates stimulated PASKIN autophosphorylation, we wondered whether 
they could also stimulate phosphorylation of the PASKIN targets S6 and eEF1A1. Therefore, wild-
type and phosphoacceptor site mutant recombinant S6 and eEF1A1 were used for PASKIN in vitro 
phosphorylation reactions in the presence of differently phosphorylated PtdIns-phosphates. As shown 
in Fig. 5, PASKIN auto-phosphorylation was again stimulated by all three PtdIns-monophosphates but 
inhibited by PtdIns(4,5)P2 and PtdIns(3,4,5)P3. While the phosphoacceptor site mutant S6 and eEF1A1 
GST fusion proteins remained unphosphorylated, their wild-tpye counterparts were phosphorylated by 
PASKIN. Unexpectedly, both S6 and eEF1A1 target phosphorylation was inhibited by PtdIns-
phosphates. The more phosphate groups the inositol ring carries, the stronger was PASKIN target 
protein phosphorylation inhibited. However, non-phosphorylated PtdIns did not significantly change 
target phosphorylation efficiency. 
 
DISCUSSION 
 
In this work, we identified various novel potential PASKIN substrates by peptide microarray 
phosphorylation, including glycogen synthase that was known before to be phosphorylated by 
PASKIN [11]. Thus, the repetitive identification of this PASKIN target confirms, at least partially, the 
validity of the peptide array approach. Other peptides derived from proteins involved in glycogen 
metabolism included phosphorylase kinase, inhibitor of protein phosphatase 1 and yeast glycogen 
phosphorylase (supplemental Table S1). The involvement of PASKIN in the regulation of glycogen 
synthesis has previously been demonstrated by showing that both mammalian and yeast glycogen 
synthases as well as yeast UDP-glucose pyrophosphorylase are known phosphorylation targets of 
mammlian PASKIN and yeast PSK1 and PSK2, respectively [8,11]. However, whereas Ser640 was 
the main PASKIN kinase target residue of mammalian glycogen synthase [11], the peptides 
phosphorylated by PASKIN on the microarray contained Ser3 and Ser7 but not Ser640. Of note, a 
Ser640Ala mutation did not completely prevent phosphorylation [11]. Therefore, our data suggest that 
PASKIN might phosphorylate Ser3 and/or Ser7 of glycogen synthase in addition to Ser640. 
 Two peptides phosphorylated by PASKIN were derived from enzymes involved in glycolysis: 
pyruvate kinase and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 (PFKFB1) (supplemental 
Table S1). Obviously, the coordination of glycolysis, gluconeogenesis and glycogen synthesis appears 
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to be physiologically meaningful, and it is hence tempting to speculate that PASKIN is involved in the 
regulation of all of these metabolic pathways. However, pyruvate kinase could not be confirmed as a 
PASKIN target using purified full-length pyruvate kinase GST fusion proteins in in vitro assays (data 
not shown). 
 Interestingly, S6 was among the peptides phosphorylated by PASKIN and this phosphorylation 
could be confirmed on the full-length protein level. Together with the previously reported eEF1A1 
phosphorylation [18], this finding provides additional evidence that PASKIN is involved in 
mammalian protein translation. The most important and best characterised S6 kinases are the mTOR 
dependent p70 S6-kinases that sequentially phosphorylate all five phosphorylatable serines of S6, 
starting with S236 and S235 - the same sites as shown herein for PASKIN - followed by S240, S244 
and S247 [25]. A second family of S6 kinases are p90 ribosomal S6 kinases (RSK) that phosphorylate 
S6 upon mitogenic stimulation at the same sites as PASKIN [22]. Phosphorylation of S6 by p70S6K 
has long been thought to increase protein translation by selectively enhancing the translation of 5'-TOP 
mRNAs, a subset of mRNAs containing an oligopyrimidine tract in their 5'-untranslated regions. Of 
note, the 5'-TOP mRNAs code for ribosomal proteins and translation factors including PASKIN 
targets S6 and eEF1A1 [26]. However, S6 phosphorylation and increased 5'-TOP mRNA translation 
might be coincidental rather than causally related [27], and, according to a newer hypothesis, might 
even negatively influence translation if phosphorylation of S6 is considered an inhibitory feed-back 
signal [28]. However, no significant difference in global (
35
S)-Met incorporation could be observed in 
Paskin
-/-
 MEFs (data not shown).  
 Based on the known functions of the PASKIN-related FixL oxygen sensor in bacteria and the 
PASKIN orthologs in yeast, and considering the lack of any obvious phenotype in Paskin knock-out 
mice kept under normal housing conditions, it is tempting to assume that PASKIN has a ligand-
mediated sensor function that becomes apparent under currently ill defined stress situations [17]. 
However, only artificial but no endogenous PASKIN ligands have been reported up to now to bind the 
PAS domain and lead to the de-repression of the kinase domain dependent autophosphorylation [7]. 
Here, we identified phospholipids as the first biologically relevant PASKIN ligands. Apparently, the 
presence of a charged phosphate moiety is required for stimulation of PASKIN kinase activity, and 
PLD, but not PLC, can convert phospholipids from low into high-affinity PASKIN ligands. However, 
we currently do not know whether PASKIN is a target of intracellular PLD cell signalling. 
 Surprisingly, PtdIns-monophosphates were found to be the best ligands of PASKIN with clearly 
higher affinities than PtdIns-diphosphates or PtdIns-triphosphate. PtdIns binding domains have been 
reported to display either well-defined three dimensional folds [29], or rather unstructured regions 
with basic (for binding of the phosphate groups) and hydrophobic residues, like in the non-canonical 
pleckstrin homology (PH) domain of Tiam1 [30]. We identified a lysine rich region, spanning from 
Lys1019 to Lys1034 of PASKIN, which shares characteristic features with non-canonical PH 
domains, including a double lysine motif (Lys1031/1032). However, mutation and deletion analyses of 
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this putative binding region did not affect lipid binding by PASKIN (data not shown). Thus, it is 
difficult to predict the PtdIns-monophosphate binding site within the PASKIN kinase domain and 
further work will be necessary to identify the specific residues involved in lipid binding.  
 Whereas PtdIns(4,5)P2 and PtdIns(3,4,5)P3 are involved in signalling processes at the plasma 
membrane, PtdIns-monophosphates are more abundant in intracellular membrane structures such as 
the Golgi apparatus and endosomes [31]. Within these structures, PtdIns-monophosphates are involved 
in sorting and signalling, since the concentrations and localization of differentially phosphorylated 
PtdIns can change rapidly [29]. Therefore, it might be possible that PtdIns-monophosphates not only 
regulate PASKIN activity but also its subcellular localization. This hypothesis needs further 
investigations but is dependent on the prior identification of the specific environmental conditions that 
regulate PASKIN function. 
 As could have been expected, we found a direct correlation between ligand affinity and 
PASKIN autophosphorylation efficiency. However, it turned out to be the kinase domain rather than 
the PAS domain which binds the PtdIns-phosphates. This finding might explain why the activation of 
PASKIN-dependent S6 and eEF1A1 target phosphorylation failed to comply with our initial 
expectations: PASKIN autophosphorylation was not directly related to target phosphorylation. 
However, our results are consistent with a recent report demonstrating that PASKIN kinase activity is 
independent of activation loop phosphorylation [19]. Thus, the original model of autophosphorylation-
dependent kinase activity needs to be revised, and the functional meaning of PASKIN 
autophosphorylation remains to be elucidated. 
 In conclusion, our in vitro data suggest similar downstream effector functions of mammalian 
PASKIN as known from yeast: the coordination between energy flux and translation. With the 
identification of endogenous small molecule activators of PASKIN, we obtained the first hints on the 
upstream regulators of PASKIN activity and it will be interesting to examine how these regulators 
affect the downstream processes mediated by PASKIN. 
 
EXPERIMENTAL PROCEDURES 
 
Plasmids 
 
All cloning work was carried out using Gateway technology (Invitrogen). The human PASKIN cDNA 
containing plasmids pENTR4-hPASK and pENTR4-hKIN, and plasmids for recombinant expression 
of full length His6-PASKIN, PASKIN truncations and eukaryotic elongation factor 1A1 have been 
published previously [18]. pENTR4-hPASK and pENTR4-hKIN were recombined into pcDNA3.1/c-
myc-DEST [32] using LR recombinase (Invitrogen) to generate pcDNA3.1/c-myc-hPASK and 
pcDNA3.1/c-myc-hKIN for c-myc-tagged expression of PASKIN or its kinase domain, respectively, 
in mammalian cells. Human ribosomal protein S6 (IRAUp969B0849D6, Deutsches 
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Ressourcenzentrum für Genomforschung) was cloned into pENTR4 using forward and reverse primers 
5'-ttatgtcgacatgaagctgaacat-3' and 5'-tacgtgcggccgcttatttctgactggattcagacttag-3', respectively, or 5'-
tacgtggcggccgcttaaagtctgcgtctcttcgc-3' to introduce a stop codon after residue L234. The PCR 
products were ligated into the SalI and NotI restriction sites. The S6 S235/236A double mutant was 
produced with primers 5'-gcgaagagacgcaggctagccgctctgcgagcttctac-3' and 5'-
gtagaagctcgcagagcggctagcctgcgtctcttcgc-3' by Pfu polymerase-based site-directed mutagenesis 
(Stratagene). For expression as GST-tagged fusion proteins, pENTR4 based plasmids with the 
different S6 constructs were recombined into pDEST15 using LR recombinase. 
 
Purification of recombinant proteins 
 
Recombinant proteins were purified as described in detail previously [18]. Briefly, full-length 
PASKIN was purified from Sf9 cells using the Bac-to-Bac Baculovirus expression system 
(Invitrogen). GST-tagged fusion constructs and His6-tagged PASKIN fragments were expressed in 
arabinose inducible BL21 E. coli. Recombinant proteins were purified by FPLC (BioLogic DuoFlow, 
Biorad) using HiTrap Chelating HP and GSTrap FF columns (GE Healthcare), respectively. The 
kinase activity of purified recombinant PASKIN was verified by auto-phosphorylation assays. 
 
Kinase assays 
 
His6-PASKIN or PKCδ (Invitrogen) were incubated with or without 2 µg recombinant target proteins 
in kinase buffer (25 mM Tris-HCl pH 7.5, 10 mM MgCl2, 1 mM DTT) for 20 minutes in the presence 
of 3 µCi (γ-
33
P)ATP (Hartmann Analytic). Proteins were separated by SDS-PAGE and analyzed by 
phosphorimaging of the dried gels (Molecular Imager FX, Bio-Rad) using Quantity One software 
(Bio-Rad). Lipids (Sigma or Fluka) were dissolved in CHCl3, aliquotted in test tubes and the CHCl3 
evaporated under a stream of nitrogen. Lipids were then resuspended in kinase assay master mixes by 
thorough vortexing. Phosphatidylinositides present in the phosphorylation reactions were obtained 
from Echelon Biosciences as synthetic diC8-lipids and added to the reactions from 1 mM aequous 
stock solutions to the final concentrations indicated. 
 
Peptide microarrays 
 
Peptide microarrays were phosphorylated with recombinant PASKIN according to the manufacturer's 
instructions (Pepscan). In brief, 50 µl of a solution containing 500 ng recombinant PASKIN, 50 mM 
HEPES pH 7.4, 20 mM MgCl2, 10% glycerol, 300 µCi/ml (γ-
33
P)ATP, 0.01% (v/v) Brij-35 and 0.01 
mg/ml BSA was added to the glass slide, covered with a glass coverslip and incubated at 30°C for 2 
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hours in a humidified incubator. After incubation, the coverslip was removed with 1% Triton X-100 in 
PBS and the glass slide was washed twice with 1% Triton X-100 in 2 M NaCl and twice with water by 
over-head shaking, air-dried and analyzed by phosphorimaging (Bio-Rad). 
 
Phosphorylation of biotinylated peptides 
 
PASKIN phosphorylation reactions were performed as described above in the presence of N-
terminally biotinylated 20-mer target peptides (JPT peptide technologies) at 200 µM final 
concentration. The reactions were stopped by adding SDS to 0.5% final concentration and heating at 
95°C for 5 minutes. Streptavidin sepharose beads (25 µl, GE Healthcare) and 500 µl of 100 mM Tris-
HCl pH 8.0 were added and incubated for 30 minutes at 4°C. The beads were washed three times with 
500 µl of a buffer containing 10 mM Tris-HCl pH 8.0, 1 mM EDTA, 400 mM NaCl, 0.1% Nonidet P-
40 and once with 500 µl 100 mM Tris pH 8.0. Phosphorylation of the beads was quantified by liquid 
scintillation counting (Tri-Carb 2900TR, Packard-Perkin Elmer). 
 
Cell culture, transfections and immunoblotting 
 
Mouse embryonic fibroblast (MEF) cells were generated from Paskin
+/+
 and Paskin
-/-
 mice [14] at 
embryonic day 14 (E14). S6K1
-/-
/S6K2
-/-
 double knock-out MEFs were kindly provided by G. Thomas 
and S. C. Kozma (Basel, Switzerland). MEF cells were cultivated in Dulbecco’s modified Eagle 
medium (DMEM, Sigma) supplemented with 10% FCS (Invitrogen) up to passage 12, implying that 
they immortalised spontaneously. MEFs were transiently transfected using Lipofectamine 2000 
(Invitrogen) according to the manufacturer's protocol. 36 hours post transfection, cells were harvested 
and whole cell lysates were generated by heating the cells in 1% SDS for 5 minutes at 95°C. After 
SDS-PAGE and immunoblotting, the following primary antibodies were used: human PASKIN 
(Affinity Bioreagents); mouse PASKIN, phospho-S6 (S235/236), S6 kinase and phospho-S6 kinase 
(T389) (Cell Signaling); S6 (Bethyl); β-actin and GST-tag (Sigma); His-tag (Novagen). 
 
Lipid binding assays 
 
Interactions between PASKIN and lipids were measured by an ELISA-based assay described 
previously [33]. Briefly, 96-well plates (Sarstedt) were coated overnight with phospholipids dissolved 
in methanol, followed by blocking with 3% BSA in PBS for 1 hour. Purified His6-PASKIN (100 ng) 
was diluted in kinase buffer and allowed to bind for 1 hour at 30°C. After three washing steps (0.3% 
Tween-20 in PBS), bound PASKIN was detected by anti-PASKIN mAb6, followed by secondary goat 
anti-mouse HRP-conjugated antibodies (Pierce) using the 3,3',5,5'-tetramethylbenzidine substrate kit 
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(Pierce). The peroxidase reaction was stopped by adding H2SO4 (1 M final concentration) and 
absorbance was determined at 450 nm in a microplate reader (Digiscan, Asys Hitech). For 
phospholipase (PL) experiments, phospholipid-coated 96-well plates were treated with 0.2 units PLC 
or PLD (Sigma), diluted in reaction buffer (120 mM CaCl2, 300 mM sodium acetate pH 5.6) for 1 hour 
at room temperature. 
 
Lipid binding arrays 
 
Membranes spotted with phospholipids were obtained from Echelon Biosciences (P-6002, P-6100) 
and used according to the manufacturer's protocol. Generally, 1 µg of protein diluted in 1% skimmed 
dry milk in TBS was allowed to bind to spotted phospholipids for 16-20 hours at 4°C. Binding was 
detected using primary antibodies as indicated and HRP-coupled secondary antibodies for enhanced 
chemiluminescence detection (Pierce). 
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SUPPORTING INFORMATION 
 
Table S1 
Rank order of the 75 most strongly phosphorylated PASKIN kinase targets on the peptide microarray. 
 
Table S2 
Sequences of the eleven biotinylated peptides tested for phosphorylation by recombinant PASKIN. 
 
 
FIGURE LEGENDS  
 
Fig. 1. Identification of novel PASKIN kinase targets. (A) Recombinant His6-PASKIN purified 
from SF9 insect cells was used for in vitro phosphorylation of a microarray of 1176 peptides in the 
presence of (γ-
33
P)-ATP. The magnified inset shows an example of the results following detection by 
phosphorimaging. (B) Peptide sequences of the 30 most phosphorylated targets and their similarities to 
PKA and PKC consensus motifs. (C) Target validation. Biotinylated peptides of 20 amino acids length 
were incubated together with recombinant PASKIN in the presence of (γ-
33
P)-ATP, captured with 
streptavidin sepharose beads and quantified by liquid scintillation counting. The sequences were 
normalised to a GYS-derived peptide, a known target for PASKIN. A PDX-1-derived peptide, another 
known PASKIN target, served as second positive control. Shown are mean values + SD of n = 3 
independent experiments. Asterisks indicate statistically significant differences compared to the 
unrelated negative control peptide derived from activating transcription factor ATF-4 (*, p < 0.05; ** 
p < 0.01; paired t-test). The peptides were named as follows: GYS, glycogen synthase; PDX1, 
pancreatic and duodenal homeobox 1; PIAS1, protein inhibitor of activated STAT 1; RAB11BP, 
RAB11-binding protein; FXN, frataxin; HERG, human ether-a-go-go related gene; CREB1, cAMP 
response element-binding protein; NFATC4; nuclear factor of activated T-cells c4; 4E-T, eIF4E-
transporter; S6, 40S ribosomal protein S6; PHKB, phosphorylase kinase β; PFKFB, 6-
phosphofructokinase/fructose-2,6-bisphosphatase. Note that some of the PASKIN target sequences as 
shown in (B) can be found in several distinct proteins, leading to the partially altered designations in 
(C), as outlined in supplemental Table S2. 
 
Fig. 2. Ribosomal protein S6 is phosphorylated by PASKIN. (A) Sequence comparison of the S6 
peptides used in the microarray, 20-mer peptide used for the in vitro reactions, and recombinant GST 
fusion proteins purified from Sf9 insect cells. (B) Phosphorylation reactions in vitro using purified 
His6-PASKIN and recombinant S6 in the presence of (γ-
33
P)-ATP. Following SDS-PAGE, the 
phosphorylated proteins were visualized by phosphorimaging. Equal input was controlled by 
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immunoblotting against S6 and the GST-tag. (C) Immunoblot analysis of the phosphorylation status of 
p70S6K and S6 in Paskin
+/+
 and Paskin
-/-
 MEFs. (D) Immunoblot analysis of the phosphorylation 
status of p70S6K and S6 in S6K1
-/-
/S6K2
-/-
 double knock-out MEFs following overexpression of a 
negative control (EGFP), myc-PASKIN or myc-KIN. Anti-myc and anti-PASKIN antibodies were 
used to confirm PASKIN overexpression. 
 
Fig. 3. Phospholipid stimulation of PASKIN autophosphorylation. (A) Lipid stimulation of PKCδ 
and PASKIN autophosporylation as assessed by incubating the purified recombinant proteins with 
DOG/PS mixtures and (γ-
33
P)-ATP. Following SDS-PAGE, the phosphorylated proteins were 
visualized by phosphorimaging. (B, C) Stimulation of PASKIN and PKCδ autophosphorylation by 
increasing amounts of the indicated phospholipids. Following SDS-PAGE, the phosphorylated 
proteins were visualized (upper panels) and quantified (lower panels) by phosphorimaging. The values 
were normalised to 100 µg/ml PS and 10 µg/ml DOG/100 µg/ml PS mixtures for PASKIN and PKCδ, 
respectively (filled columns). (D) PLD but not PLC converts PC from a low affinity to a high affinity 
PASKIN ligand. 96-well plates were coated with increasing amounts of PC, followed by treatment 
with PLD or PLC as indicated. Binding of 100 ng PASKIN added to each well was detected by 
ELISA. Shown are mean values ± SD of a representative experiment performed in triplicates 
 
Fig. 4. Preferential PASKIN binding to, and activation by, phosphatidylinositol 
monophosphates. (A) Recombinant His6-PASKIN protein was allowed to bind to the indicated lipids 
immobilised on a membrane, and subsequently detected using an anti-PASKIN antibody. (B) PASKIN 
dose-dependently bound preferably phospatidylinositol (PtdIns) monophosphates. PASKIN was either 
detected by immunoblotting (left panel) or by phosphorimaging following autophosphorylation in the 
presence of (γ-
33
P)-ATP (right panel). (C) Fragments of PASKIN were expressed in E. coli and 
purified as His6-tagged fusion proteins (left panel). Following binding to the lipid dot blots and 
detection using a His-tag antibody, only the kinase (KIN) domain of PASKIN was found to interact 
with PtdIns-monophosphates (right panel). (D) His6-PASKIN autophosphorylation was mainly 
stimulated by the presence of the PtdIns-monophosphates. In vitro phosphorylation reactions in the 
presence of (γ-
33
P)-ATP and the indicated synthetic diC8 PtdIns (3.16 µM, 10 µM, 31.6 µM and 100 
µM) were separated by SDS-PAGE and quantified by phosphorimaging. Values were expressed 
relative to lipid-free control reactions and are represented as mean + SD of n = 4 independent 
experiments (*, p < 0.05; ** p < 0.01; ***, p < 0.001; t-test). 
 
Fig. 5. In vitro target phosphorylation of His6-PASKIN is reduced in presence of 
phosphatidylinositides. Recombinant His6-PASKIN purified from Sf9 insect cells was used to in 
vitro phosphorylate recombinant GST fusion proteins with wild-type S6, with the non-
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phosphorylatable double mutant S235/236A, with eEF1A1, or with its non-phosphorylatable T432A 
mutant, in the presence of (γ-
33
P)-ATP and PtdIns phosphates (100 µM) as indicated. Following 
separation by SDS-PAGE, protein phosphorylation was viusalized (left panel, representative images) 
and quantified (right panel) by phosphorimaging. His6-PASKIN autophosphorylation without lipid and 
target (first lane from the left) was used for intra-assay normalisation of the values. Columns represent 
mean values + SD of n = 3 independent experiments (*, p < 0.05; ** p < 0.01; ***, p < 0.001; t-test). 
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Target Protein Gene Symbol Species Swissprot Sequence Length Phosphosite Known kinase Radioactivity
Lamin B receptor LBR chicken P23913 SRSRSRSRS 9 S-80 SRPK1 / LBRK 14628.8
Lamin B receptor LBR chicken SRSRSRSPG 9 S-82 SRPK1 / LBRK 3816.9
Lamin B receptor LBR chicken RRSRSRSRS 9 S-78 SRPK1 / LBRK 2472.0
Peptide derived from cAMP dependent Protein Kinase Inhibitor alpha (14-22aa) PKIA human P61925 GRTGRRNSI 9 S-8 / 14221.6
Phosphorylase b kinase β regulatory chain PHKB human Q93100 RTGRSGSV 8 S-26 (K24G) PKA 10948.7
Phosphorylase b kinase β regulatory chain PHKB human RTKRSGSV 8 S-26 PKA 5074.4
Phosphorylase b kinase beta regulatory chain PHKB rabbit P12798 RSKRSGSV 8 S-26 (T23S) PKA 4953.5
Phosphorylase b kinase beta regulatory chain PHKB rabbit ARTKRSGSV 9 S-26 PKA 3528.0
Phosphorylase b kinase beta regulatory chain PHKB rabbit RTKRSGSV 8 S-26 PKA 2856.0
Phosphorylase b kinase beta regulatory chain PHKB rabbit RAKRSGSV 8 S-26 (T23A) PKA 2058.5
Microtubule-associated protein TAU MAPT human P10636 SRSRTPSLP 9 T-212 GSK3 10459.9
Myelin Basic Protein MBP bovine P02687 GRGLSLSR 8 S-136 / 10191.0
Voltage-dependent L-type calcium channel alpha-1S subunit CACNA1S rabbit P07293 SRRSSLGSL 9 S-1854 PKA 8368.0
Voltage-dependent L-type calcium channel alpha-1S subunit CACNA1S rabbit QRRTSLTGS 9 S-1757 PKA 7337.6
cAMP response element binding protein CREB1 human P16220 REILSRRPS 9 S-129 GSK3 8292.6
Pyruvate kinase isozyme L PKLR bovine / RRASLG 6 S-12 PKA 6524.6
Pyruvate kinase isozyme L PKLR bovine LRRGSLG 7 S-12 (A11G; A14G) PKA 5140.2
Pyruvate kinase isozyme L PKLR bovine LRRASLG 7 S-12 PKA 4409.3
Pyruvate kinase isozyme L PKLR bovine LRRATLG 7 S-12 (S12T) PKA 3538.9
Pyruvate kinase isozyme L PKLR bovine LRRPSLG 7 S-12 (A11P) PKA 2409.1
Pyruvate kinase isozyme L PKLR bovine LRRASLAG 8 S-12 (G14A) PKA 2347.2
Pyruvate kinase isozyme L PKLR bovine LRRASLRG 8 S-12 (G14R) PKA 2205.1
Pyruvate kinase isozymes R/L PKLR rat P12928 RRASS 5 S12/S-43 (V44S) PKA 6374.1
Pyruvate kinase isozymes R/L PKLR rat RRGSV 5 S12/S-43 (A42G)) PKA 5923.5
Pyruvate kinase isozymes R/L PKLR rat RRATVA 6 S12/S-43 (S43T) PKA 5449.2
Pyruvate kinase isozymes R/L PKLR rat RRVSV 5 S12/S-43 (A42V) PKA 5410.7
Pyruvate kinase isozymes R/L PKLR rat RRRRAASVA 9 PKA 5166.8
Pyruvate kinase isozymes R/L PKLR rat RRASL 5 S12/S-43 (V44L) PKA 5082.9
Pyruvate kinase isozymes R/L PKLR rat RRRASVA 7 PKA 4982.9
Pyruvate kinase isozymes R/L PKLR rat RRRRPTPA 8 PKA 4964.1
Pyruvate kinase isozymes R/L PKLR rat RRRRSVA 7 S12/S-43 (L39R; A42R)PKA 4591.3
Pyruvate kinase isozymes R/L PKLR rat RRFSV 5 S12/S-43 (A42F) PKA 3823.5
Pyruvate kinase isozymes R/L PKLR rat RRASI 5 S12/S-43 (V44I) PKA 3464.9
Pyruvate kinase isozymes R/L PKLR rat RRRRASVA 8 S12/S-43 (Y38R; L39R)PKA 2645.2
Pyruvate kinase isozymes R/L PKLR rat RRAASVA 7 S12/S-43 (L39R; R41A)PKA 2341.2
Pyruvate kinase isozymes R/L PKLR rat RRASR 5 S12/S-43 (V44R) PKA 2182.3
Pyruvate kinase isozymes R/L PKLR rat LRRASVA 7 S12/S-43 PKA 2170.1
Pyruvate kinase isozymes R/L PKLR rat RRASVA 6 S12/S-44 PKA 2079.1
Pyruvate kinase isozymes R/L PKLR rat RRPSV 5 S12/S43 (A42P) PKA 2028.6
40S ribosomal protein S6 RPS6 human P62753 RRLSSLRAS 9 S-236 S6K 6258.7
Neutrophil cytosol factor 1 NCF1 human P14598 PPRRSSIRN 9 S-303 / 5853.3
Glial fibrillary acidic protein GFAP bovine Q28115 RRVTSATRR 9 S-8 PKA 5674.0
Glial fibrillary acidic protein GFAP bovine Q28115 ATRRSYVSS 9 S-13 PKA 3168.5
Protamine Z1and Z2 PRM2 tuna P02322 RRSTVA 6 T-21 PKA 5571.2
Protamine Z1 and Z2 PRM2 salmon (clupa) P02336 RRRRSRRAS 9 S-6 PKA and PKC 4681.7
Protamine YI PRM3 salmon (clupa) P02337 RRSSSRPIR 9 S-8 PKA and PKC 4905.9
Heat shock protein 27 HSPB1 human P04792 SRALSRQLS 9 S-78 MAPKAPK2 5046.3
Inhibitor of protein phosphatase 1 PPP1R1A rabbit P01099 RRPTVA 6 T-35 PKA 4772.6
cAMP-dependent protein kinase type II-alpha regulatory subunit PRKAR2A bovine P00515 REARSRAST 9 S-44 GSK3 4407.1
Vitronectin [precursor] VTN human P04004 SRRPSRATW 9 S-397 PKA 4181.5
Keratin, type II cytoskeletal 8 KRT8 human P05787 FSSRSYTSG 9 S-23 / 3799.4
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 PFKFB1 rat P07953 RRRGSSIPQ 9 S-32 PKA 3746.0
Ras-related protein Rab-4A RAB4A human P20338 RQLRSPRRT 9 S-199 p34cdc2 3628.9
ATP citrate synthase ACLY rat P16638 TRAPSRTAS 9 S-450 MFPK 3514.9
Myosin IC heavy chain MYSC macaque P10569 RGRSSVYSA 9 S-311 myosin 3502.2
Hepatocyte growth factor receptor [precursor] MET human P08581 DRLVSARSV 9 S-985 PKC 2892.5
Acetylcholine receptor protein, delta subunit [precursor] ACHD torpedo californica P02718 RRSSSVGYI 9 S-383 PKA 2838.3
glycogen (starch) synthase GYS1 rabbit P13834 PLSRTLSVS 9 S-7 PKC/CAMII 2791.9
Lysozyme C [precursor] LYC chicken P00698 RGYSLG 6 S-42 PKA 2776.0
Interleukin-2 receptor alpha chain [precursor] IL2RA human P01589 RQRKSRRTI 9 S-268 PKC 2594.4
Troponin I, cardiac muscle TNNI3 rabbit P02646 GRALSTRAQ 9 S-72 PhK 2521.8
Troponin I, cardiac muscle TNNI3 rabbit P02646 RRRS 4 S-20 (V17R) PKA 2010.5
Glycogen phosphorylase GPH1 yeast P06738 TRRLTGFLP 9 T-30 / 2475.4
Desmin DES chicken P02542 GSRGSGSSV 9 S-35 PKA 2451.3
Desmin DES chicken P02542 QRVSSYRRT 9 S-12 PKC 2234.4
Ryanodine receptor 2 RYR2 rabbit P30957 TRRISQTSQ 9 S-2809 CaM-II 2394.6
Lamin-A LMNA human P02545 RGRASSHSS 9 S-403 PKC 2303.7
Lamin-A LMNA human P02545 TVTRSYRSV 9 S-625 PKC 2030.6
Inositol 1,4,5-trisphosphate receptor type 1 ITPR1 rat P29994 GRRESLTSF 9 S-1755 PKA 2290.7
Vimentin VIM mouse P20152 STSRSLYSS 9 S-50 PKA 2181.2
Vimentin VIM mouse P20152 SRPSSNRSY 9 S-25 autophosphorylation 2147.0
Lamin-B1 LMNB1 human P20700 RASSSRSVR 9 S-405 PKC 2084.2
Fibrinogen alpha chain [precursor] FGA human P02671 TTRRSASKT 9 S-460 PKA 2036.1
Parathyroid hormone/parathyroid hormone-related peptide receptor [precursor] PTH1R Didelphis marsupialis virginiana P25107 ARSGSSTYS 9 S-485 PKA 2029.3
Protein phosphatase 1 regulatory subunit 3A PPP1R3A rabbit  Q00756 SPQPSRRGS 9 S-44 GSK3 2004.9
Table S1.  Rank order of the 75 most strongly phosphorylated PASKIN kinase targets on the peptide microarray.
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Target Sequence 
(Gene Symbol) 
Biotinylated Peptide Swissprot Described 
Phosphorylation sites 
Kinase References 
GYS 631-AQGYRYPRPASVPPSPSLSR-650 P13807 S641 
S645 
S649 
PASKIN, GSK3 
GSK3 
GSK3 
[1,2] 
[2] 
[2] 
PDX1 141-AEPEENKRTRTAYTRAQLLE-160 P52945 T152 PASKIN [3] 
PIAS1 500-HQASPVSRTPSLPAVDTSYI-519 O75925 S503 
S510 
unknown 
unknown 
[4,5] 
[5] 
RAB11BP 427-KKPESRRSSLLSLMTGKKDV-446 Q6WKZ4 S435 unknown [4,6] 
FXN  48-ATCTPRRASSNQRGLNQIWN-67 Q16595 none   
HERG 276-CASVRRASSADDIEAMRAGV-295 Q12809 S283 PKA [7] 
CREB1 120-DSQKRREILSRRPSYRKILN-139 P16220 S121 
S129 
S133 
several 
several 
several 
[8] 
[8] 
[8] 
NFATC4 280-ASPALSRRGSLGEEGSEPPP-299 Q14934 S281 
S285 
S289 
RSK2 
RSK2 
RSK2 
[9] 
[9] 
[9] 
4E-T 343-NPSRSGSRSSSLGSTPHEEL-362 Q9NRA8 S345 unknown [4] 
RPS6 226-EQIAKRRRLSSLRASTSKSE-245 P62753 S235 
S236 
S240 
S244 
S6K/RSK 
S6K/RSK 
S6K 
S6K 
[10,11] 
[10,11] 
[10] 
[10] 
PHKB  17-ERRARTKRSGSVYEPLKSIN-36 Q93100 S25 
S27 
unknown 
unknown 
[12] 
[4,12] 
PFKFB  26-RLQRRRGSSIPQFTNSPTMV-45 P16118 S33 
S34 
PKA, PKG 
PKA, PKG 
[13] 
[13] 
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Table S2. Sequences of the eleven biotinylated peptides tested for phosphorylation by 
recombinant PASKIN. Control peptides were derived from glycogen synthase(GYS) and 
pancreatic and duodenal homeobox (PDX)1 which have been reported previously to be 
phosphorylated by PASKIN. The other sequences tested were derived from the peptide 
microarray (underlined) and extended to 20 amino acids as indicated. Because some of the 
short sequences of the peptide microarray form consensus motifs, they can be found in 
multiple proteins. Therefore, some of the designations of the peptide microarray differ from 
the 20-mer biotinylated peptides. Abbreviations: GYS, glycogen synthase; PDX1, pancreatic 
and duodenal homeobox 1; PIAS1, protein inhibitor of activated STAT 1; RAB11BP, Rab11-
binding protein; FXN, frataxin; HERG, human ether-a-go-go related gene; CREB1, cAMP 
response element-binding protein 1; NFATC4, nuclear factor of activated T-cells c4; 4E-T, 
eIF4E-transporter; RPS6, 40S ribosomal protein S6; PHKB, phosphorylase kinase β; PFKFB, 
6-phosphofructokinase/fructose-2,6-bisphosphatase; MAPT, microtubule-associated protein 
tau; CACNA1S, calcium channel, voltage dependent, L type, alpha 1S subunit; PKLR, 
pyruvate kinase, liver and red blood cell; GSK3, glycogen synthase kinase 3; PKA, protein 
kinase A; S6K, p70 S6 kinase; RSK, p90 ribosomal S6 kinase; PKG, protein kinase G. 
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